Zevra Therapeutics, Inc. ZVRA Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $95.6M+53.2% | $62.41M+14.6% | $54.44M+14.1% | $47.71M+27.8% | $37.34M+10.5% | ||
| $105.02M-18.3% | $128.61M-11.3% | $145.07M-6.3% | $154.9M+512% | $25.29M-29.2% | ||
| $22.1M-5.0% | $23.26M+38.1% | $16.84M-7.8% | $18.27M+44.8% | $12.62M+20.1% | ||
| $0-100% | $879K+22.1% | $720K-7.9% | $782K-92.6% | $10.62M-3.5% | ||
| $229.97M+3.1% | $223.01M-0.9% | $225.12M-0.5% | $226.34M+177% | $81.57M-5.2% | ||
| $430K-12.1% | $489K+0.2% | $488K-18.5% | $599K+41.9% | $422K+18.5% | ||
| $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | $4.7M0.0% | ||
| $6.11M-4.9% | $6.42M-4.7% | $6.74M-4.5% | $7.05M-89.5% | $67.38M-2.3% | ||
| $278.58M-2.2% | $284.73M+5.4% | $270.12M+5.4% | $256.28M+48.4% | $172.71M-3.0% | ||
| $11.69M+0.8% | $11.6M+4.8% | $11.07M-30.1% | $15.84M-11.1% | $17.82M-30.0% | ||
| $47.03M+19.7% | $39.28M+50.4% | $26.11M-9.4% | $28.83M+6.9% | $26.98M-20.8% | ||
| $0-100% | $61.93M+1.0% | $61.31M+1.0% | $60.69M+1.0% | $60.09M+1.0% | ||
| $8.16M-26.6% | $11.12M-91.9% | $136.95M-1.5% | $139.05M+5.6% | $131.69M-4.9% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K+20.0% | $5K0.0% | ||
| -$384.17M+9.0% | -$422.06M+2.8% | -$434.23M-0.1% | -$433.68M+14.7% | -$508.39M-0.6% | ||
| $205.8M+33.1% | $154.66M+16.1% | $133.17M+13.6% | $117.23M+186% | $41.02M+3.4% | ||
| $278.58M-2.2% | $284.73M+5.4% | $270.12M+5.4% | $256.28M+48.4% | $172.71M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Zevra Therapeutics, Inc.'s total assets?
- Zevra Therapeutics, Inc. (ZVRA) holds $278.6M in total assets, up 61.3% year over year.
- How much debt does Zevra Therapeutics, Inc. have?
- Zevra Therapeutics, Inc. carries $1.1M in total debt against $205.8M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Zevra Therapeutics, Inc. have?
- Zevra Therapeutics, Inc. holds $95.6M in cash and equivalents.
- Can Zevra Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 4.89 — current assets exceed current liabilities.
- Where does Zevra Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
